Actemra 80 mg/4 mL injection Images
Generic Name: tocilizumab
This medication has been identified as Actemra 80 mg/4 mL injection and is used for Giant Cell Arteritis, COVID-19, Rheumatoid Arthritis, Cytokine Release Syndrome, and Polyarticular Juvenile Idiopathic Arthritis. It belongs to the drug class interleukin inhibitors and is not a controlled substance.
Images of medication
Actemra
- Generic Name
- tocilizumab
- Strength
- 80 mg/4 mL injection
- Availability
- Prescription only
- Drug Class
- Interleukin inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0135
See also:
More about Actemra (tocilizumab)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (49)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Support group
- FDA approval history
- Drug class: interleukin inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.